Acute myelogenous leukemia (AML) originates from hematopoietic stem/progenitor cells and is maintained by a subset of leukemia stem cells (LSCs), which are assumed to be enriched for the CD34+/CD38− fraction [1–3]. This evidence concerns the gene CD34 and leukemia.